Prostate carcinoma. Surgical management of regional disease.

Abstract

CancerVolume 78, Issue 12 p. 2455-2460 CommentaryFree Access Prostate carcinoma: Surgical management of regional disease Robert P. Gibbons M.D., Corresponding Author Robert P. Gibbons M.D. Virginia Mason Medical Center, Seattle, WashingtonVirginia Mason Medical Center, 1100 Ninth Avenue C7-URO, P.O. Box 900, Seattle, WA 98111===Search for more papers by this author Robert P. Gibbons M.D., Corresponding Author Robert P. Gibbons M.D. Virginia Mason Medical Center, Seattle, WashingtonVirginia Mason Medical Center, 1100 Ninth Avenue C7-URO, P.O. Box 900, Seattle, WA 98111===Search for more papers by this author First published: 15 December 1996 https://doi.org/10.1002/(SICI)1097-0142(19961215)78:12<2455::AID-CNCR1>3.0.CO;2-JAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Murphy GP, Natarajan N, Pontes IE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 1982; 127: 928– 34. 2 Stamey TA, McNeal JE. Adenocarcinoma of the prostate. In: PC Walsh, AB Retik, TA Stamey, ED Vaughn, editors. Campbell's Urology. 6th edition. Philadelphia: WB Saunders, 1992; 1159– 221. 3 Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 147: 1574– 5. 4 Petros JA, Catalona WJ. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 1992; 147: 1574– 5. 5 van den Ouden D, Davidson PJT, Hop W, Schroeder FH. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 1994; 151: 646– 51. 6 Lerner SE, Blute ML, Zincke H. Extended experience with radical prostatectomy for clinical Stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 1995; 154: 1447– 52. 7 Gerber GS, Thisted RA, Chodak GW, Rukstalis DB, Paulson DF, Middleton AW, Ohori M, Scardino PT, Frohmuller HGW, Schroeder FH, Smith JA Jr. Results of radical prostatectomy in men with locally advanced (clinical Stage T3) prostate cancer: multi-institutional analysis [abstract 1194]. J Urol 1996; 155 (Suppl): 609A. 8 Lerner SE, Blute ML, Zincke H. Primary surgery for clinical Stage T3 adenocarcinoma of the prostate. In: NJ Vogelzang, PT Scardino, WU Shipley, DS Coffey, editors. Comprehensive textbook of genitourinary oncology. Baltimore: Williams & Wilkins, 1996: 803– 11. 9 van den Ouden D, Davidson PJ, Schroeder FH. Surgical treatment of locally advanced (T3) carcinoma of the prostate. Br J Urol 1993; 71: 75– 6. 10 King-Menzer D, Mansfield JT, Middleton RG. Long-term outcomes of patients with Stage D1 prostate cancer: a minimum of 10 years of follow-up [abstract 1197]. J Urol 1996; 155(Suppl): 610A. 11 McCullough DK, Leadbetter WF. Radical pelvic surgery for locally extensive carcinoma of the prostate. J Urol 1972; 108: 939– 43. 12 Moul JW, Paulson DF. The role of radical surgery and the management of radiation recurrent and large volume prostate cancer. Cancer 1991; 68: 1265– 71. 13 Scott WW, Boyd HL. Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advance carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Urol 1969; 101: 86– 92. 14 Narayan P, Lowe BA, Carroll PR, Thompson IM. Neoadjuvant hormonal therapy and radical prostatectomy for clinical Stage C carcinoma of the prostate. Br J Urol 1994; 73: 544– 8. 15 Morgan WR, Myers RP. Endocrine therapy prior to radical retropubic prostatectomy for clinical stage C prostate cancer: pathologic and biochemical response [abstract 414]. J Urol 1991; 145: 316A. 16 MacFarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrun A, deKernion J. Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol 1993; 150: 132– 4. 17 Witjes WPJ, Oosterhof GON, Schaafsma HE, Debruyne FMJ. Currrent status of neoadjuvant therapy in localized prostate cancer. Prostate 1995; 27: 297– 303. 18 Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. Preoperative androgen deprivation therapy: artificial lowering of serum prostate-specific antigen without downstaging the tumor. J Urol 1993; 149: 779– 82. 19 Lim AJ, Brandon AH, Fiedler J, Bricksman AL, Boyer CI, Raub WA Jr., Soloway MS. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995; 154: 1420– 5. 20 Bagshaw MA, Kaplan ID, Cox RC. Radiation therapy for localized disease. Cancer 1993; 71: 939– 52. 21 Zagars GK, von Eschenbach AC, Ayala AG, Schultheiss TE, Sherman NE. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer 1991; 68: 2370– 7. Volume78, Issue1215 December 1996Pages 2455-2460 ReferencesRelatedInformation